The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance
Open accessAbstract
BACKGROUND: Recent reports have demonstrated a decline in bacterial bloodstream infections (BSIs) following adherence to central line insertion practices; however, declines have been less evident for BSIs due to Candida species. METHODS: We conducted active, population-based laboratory surveillance for candidemia in metropolitan Atlanta, GA and Baltimore, MD over a 5-year period. We calculated annual candidemia incidence and antifungal drug resistance rates. RESULTS: We identified 3,848 candidemia cases from 2008-2013. Compared with 2008, candidemia incidence per 100,000 person-years decreased significantly by 2013 in both locations (GA: 14.1 to 9.5, p<0.001; MD: 30.9 to 14.4, p<0.001). A total of 3,255 cases (85%) had a central venous catheter (CVC) in place within 2 days before the BSI culture date. In both locations, the number of CVC-associated cases declined (GA: 473 to 294; MD: 384 to 151). Candida albicans (CA, 36%) and Candida glabrata (CG, 27%) were the most common species recovered. In both locations, the proportion of cases with fluconazole resistance decreased (GA: 8.0% to 7.1%, -10%; MD: 6.6% to 4.9%, -25%), while the proportion of cases with an isolate resistant to an echinocandin increased (GA: 1.2% to 2.9%, +147%; MD: 2.0% to 3.5%, +77%). Most (74%) echinocandin-resistant isolates were CG; 17 (<1%) isolates were resistant to both drug categories (multidrug resistant [MDR], 16/17 were CG). The proportion of CG cases with MDR Candida increased from 1.8% to 2.6%. CONCLUSIONS: We observed a significant decline in the incidence of candidemia over a five-year period, and increases in echinocandin-resistant and MDR Candida. Efforts to strengthen infection control practices may be preventing candidemia among high-risk patients. Further surveillance for resistant Candida is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Findings from EIP surveillance data have indicated a decrease in overall candidemia incidence in their longest-running surveillance sites of Atlanta, GA, and Baltimore, MD, with the incidence of all species decreasing except C. tropicalis [8].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A more nuanced assessment using data from active population-based surveillance showed the incidence of candidemia decreased from 2008 to 2017 across multiple US sites,25,27,35 with a coincident increase in the incidence of IC from non-blood sources, including abdominal sterile sites, from 2009–2017.34”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [35]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In population-based surveillance performed in the metropolitan areas of Atlanta, Georgia, and Baltimore, Maryland, candidemia incidence (primarily among adults) increased 10%–40% from the early 1990s and the late 2000s, which was followed by more recent reports of decreases in these areas (6,28–30).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This contrasts with data from the early 1990s, when infants had the highest incidence (6), followed by substantial decreases by the late 2000s (26,28).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [28]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“although C. glabrata has been reported to represent more than 30% of the non-albicans Candida in some geographic areas [4, 6–9].”
From Invasive candidiasis species distribution and trends, United States, 2009-2017 (2021) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Population-based surveillance in two U.S. metropolitan areas found that annual candidemia incidence per 100,000 population declined during 2008–2013 (from 14.1 to 9.5 in Atlanta and 30.9 to 14.4 in Baltimore), likely because of improved infection prevention and control practices (17).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [17]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Limited data from resource-limited settings suggest that timely administration of antimicrobials in patients with sepsis and septic shock is beneficial and potentially feasible (121-126).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [122]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The percentage of Black patients affected by candidemia increased during the study period, likely mirroring the disproportionate effect of the COVID-19 pandemic on Black patients (3,17,25).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021 (2025) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“Candida strains with acquired resistance to echinocandins, specifically C. glabrata, while still generally infrequent, are increasing in incidence in some hospitals [10,14].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [10]
In the citing paper
“Specifically, C. glabrata has become an important pathogen in North America, Europe (with the exception of Spain), and Australia, whereas C. parapsilosis is the dominant non-albicans species in South America, Japan, and Spain [8,9,10].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [10]
In the citing paper
“The use of echinocandins and development of cross-resistance is creating apprehension, for the signs of multidrug resistance amongst azoles and echinocandins have already been described [168,169,170].”
From Candida glabrata Biofilms: How Far Have We Come? (2017) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU
Pronovost, P., Needham, D., Berenholtz, S., Sinopoli, D., Chu, H., Cosgrove, S., Sexton, B., Hyzy, R., Welsh, R., Roth, G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061115 · Cited by 4,387
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Health Care–Associated Infections
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., Keohane, C. A., Denham, C. R., & Bates, D. W. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.9763 · Cited by 1,927
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778
Vital Signs: Central Line–Associated Blood Stream Infections—United States, 2001, 2008, and 2009
Liang, S. Y., & Marschall, J. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.07.035 · Cited by 471
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Self-citationCleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366
Self-citationSchulman, J. D., Stricof, R. L., Stevens, T. P., Horgan, M. J., Gase, K., Holzman, I. R., Koppel, R. I., Nafday, S. M., Gibbs, K., Angert, R. M., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2873 · Cited by 313
Flagged first, then by citations
Research works printed but not linked: 1
- J Schulman, 2011, Statewide NICU Central-Line-Associated Bloodstream Infection Rates Decline After Bundles and Checklists, Pediatrics, 127, 436, 10.1542/peds.2010-2873 · DOI
Cited by
Sorted by citations
Items 201–300 of 305
Walter, J.-C., Kissmann, A., Gruber, D., Alpízar-Pedraza, D., Martell-Huguet, E. M., Preising, N., Rodríguez, A., Ständker, L., Kleber, C., Knoll, W., et al. (2025) · Biomolecules · doi:10.3390/biom15030322 · Cited by 7
Mucocutaneous Candida Infections in Immunocompromised Patients
Chahine, A., Farooqi, S., Marzvanyan, A., Michael, M., Chavez-Frazier, A., & Guzman, N. (2022) · Current Dermatology Reports · doi:10.1007/s13671-022-00356-7 · Cited by 6
Dudakova, A., Blei, C., Groß, U., & Schulze, M. H. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.03.054 · Cited by 6
Vázquez-Muñoz, R., Thompson, A. K., Sobue, T., & Dongari‐Bagtzoglou, A. I. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01734-23 · Cited by 6
Oud, L. (2015) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2387w · Cited by 6
Genetically Compromising Phospholipid Metabolism Limits Candida albicans’ Virulence
Wong, D., Plumb, J., Talab, H., Kurdi, M., Pokhrel, K., & Oelkers, P. M. (2019) · Mycopathologia · doi:10.1007/s11046-019-00320-3 · Cited by 6
Recent changes in candidemia trends in a tertiary hospital (2011–2018)
Piqueras, A. I., Rubio, T. T., Medina, E. M. L., Gimeno, A., Modesto, V., Cantón, E., & Pemán, J. (2020) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2020.09.005 · Cited by 6
Tsou, P., Yo, C., Hsein, Y.-C., Yungtum, G., Hsu, W., Chung, J.-Y., Su, K., Chang, A., Chang, I.-J., & Lee, C. (2021) · Journal of Intensive Care Medicine · doi:10.1177/08850666211053778 · Cited by 6
Molecular Techniques and Target Selection for the Identification of Candida spp. in Oral Samples
Magalhães, J., Correia, M. J., Silva, R. M., Esteves, A. C., Alves, A., & Duarte, A. S. (2022) · Applied Sciences · doi:10.3390/app12189204 · Cited by 11
Emerging Fungal Infections and Cutaneous Manifestations in Immunosuppressed Patients
Varghese, J. A., Guhan, S. M., & Zheng, L. (2023) · Current Dermatology Reports · doi:10.1007/s13671-023-00386-9 · Cited by 6
Vázquez-Muñoz, R., Thompson, A. K., Sobue, T., & Dongari‐Bagtzoglou, A. I. (2024) · mBio · doi:10.1128/mbio.02416-24 · Cited by 7
Moncada, P. A., Cándelo, K. D., Sierra‐Ruiz, M., Rosso, F., Martínez, L. F., Paz, D., Pacheco, R., & Cuartas, M. A. (2020) · Infectio · doi:10.22354/in.v24i3.858 · Cited by 5
Asai, N., Sakanashi, D., Suematsu, H., Kato, H., Hagihara, M., Shiota, A., Koizumi, Y., Yamagishi, Y., & Mikamo, H. (2020) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2020.11.003 · Cited by 5
Wulandari, A., Hapsari, R., Mujahidah, Sari, D., Puspitasari, I., & Pramukarso, D. T. (2021) · Journal of Clinical Microbiology and Infectious Diseases · doi:10.51559/jcmid.v1i2.5 · Cited by 5
Leite, D. P. (2023) · Virology & Immunology Journal · doi:10.23880/vij-16000331 · Cited by 5
Mpakosi, A., Siopi, M., Falaina, V., Siafakas, N., Roilides, E., Kimouli, M., Theodoraki, M., Karle, P., & Meletiadis, J. (2016) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2016.08.002 · Cited by 5
Decrease in Candida bloodstream infections in veterans in Atlanta
Kabbani, S., Jacob, J. T., Gaynes, R. P., & Rimland, D. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.11.003 · Cited by 5
García‐Romero, M. T. (2019) · Harper's Textbook of Pediatric Dermatology · doi:10.1002/9781119142812.ch47 · Cited by 5
Changes in Prevalence of Health Care–Associated Infections
Magill, S. S., O’Leary, E. N., & Edwards, J. R. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1817140 · Cited by 5
Antifungal Efficacy of Plant Essential Oils Against Candida, Aspergillus and Cryptococcus Species
Kumari, K. M. U., Imam, M. W., & Luqman, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_5 · Cited by 4
Zheng, L., Dong, Y., Wang, J., Jia, Y., Wang, W., Xu, Y., & Guo, L. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1519323 · Cited by 6
Update on the Diagnosis of Candidemia and Invasive Candidiasis
González-Lara, M. F., & Ostrosky-Zeichner, L. L. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00367-1 · Cited by 4
Dudiuk, C., Theill, L., Gamarra, S. P., & García‐Effrón, G. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0294-5 · Cited by 4
Veselov, A. V., Vasilyeva, N. V., Богомолова, Т. С., Рудольфовна, Р. Е., Kutsevalova, O. Y., Нижегородцева, И. А., Петрова, Л. В., Shmidt, N. V., Moskvitina, E. N., Витальевна, С. М., et al. (2018) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2018.1.49-54 · Cited by 4
Fundamentals of Mycology for Infection Control and Prevention
Lee, R., Cho, S., & Lee, D. (2020) · Korean Journal of Healthcare-Associated Infection Control and Prevention · doi:10.14192/kjicp.2020.25.2.86 · Cited by 4
Challenges in Invasive Fungal Disease
Chakrabarti, A., & Singh, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-9349-5_18 · Cited by 4
Mylonakis, E. E., Clancy, C. J., Ostrosky‐Zeichner, L., Garey, K. W., Alangaden, G. J., Vázquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ357 · Cited by 4
Lin, W., Yang, Q., Lin, Z., Liu, S., Zhang, L., Jiang, Y., Fang, J., Peng, Y., & Guo, P. (2025) · Mycopathologia · doi:10.1007/s11046-025-00972-4 · Cited by 3
Cohen, N., Orenbuch‐Harroch, E., Olshtain‐Pops, K., Lachish, T., & Korem, M. (2023) · Mycopathologia · doi:10.1007/s11046-023-00755-9 · Cited by 3
Anaya, E. U., & Neumann, A. K. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2019.11.1432 · Cited by 3
Yeast Infections After Solid Organ Transplantation
McCarty, T. P., & Pappas, P. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_38 · Cited by 3
Immunological Identification of Fungal Species
Nogueira, F., Istel, F., Pereira, L., Tscherner, M., & Kuchler, K. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_20 · Cited by 3
Jakubovics, N. S. (2017) · Virulence · doi:10.1080/21505594.2017.1353864 · Cited by 3
Anaya, E. U., Amin, A. E., Wester, M. J., Danielson, M. E., Michel, K. S., & Neumann, A. K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/824995 · Cited by 3
Paccoud, O., Lortholary, O., Imbert, S., Letscher‐Bru, V., Sitbon, K., Obadia, T., Dalle, F., Hasseine, L., Morio, F., Huguenin, A., et al. (2025) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2025.101365 · Cited by 2
Baker, C. P., Laba, S., Warner, J., Shepherd, K., Wilson, H. M., & Arthur, J. S. C. (2026) · Scientific Reports · doi:10.1038/s41598-026-39429-z · Cited by 3
Chen, Y.-C., Ho, M., Chao, W., & Chang, C. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823000894 · Cited by 2
Tosun, M. İ., & Kirişçi, Ö. (2024) · ANKEM Dergisi · doi:10.54962/ankemderg.1471996 · Cited by 2
Antypenko, L., Antypenko, O., Fominichenko, A., Karnaukh, I., Коваленко, С. І., & Arisawa, M. (2024) · Journal of Fungi · doi:10.3390/jof10120816 · Cited by 2
Kim, K. Y., Kim, G. Y., & Kim, J. K. (2025) · Mycobiology · doi:10.1080/12298093.2025.2461336 · Cited by 2
Sabadin, C. E. S., Lima, S. L., Gompertz, O. F., Santana, G. N. P., Melo, A. S. D. A., Rigo, L., da Matta, D. A., & Barbosa, D. A. (2020) · Medical Mycology · doi:10.1093/mmy/myaa085 · Cited by 2
Powder diet exacerbates oropharyngeal candidiasis in a mouse model
Vázquez-Muñoz, R., Thompson, A. M., Sobue, T., & Dongari‐Bagtzoglou, A. I. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.01713-23 · Cited by 2
The structure of the oropharyngeal genus Candida fungi community in HIVinfected patients
Voropaev, A. D., Yekaterinchev, D. A., Nesvizhsky, Y. V., Zverev, V. V., Afanasiev, S. S., Volchkova, E. V., Afanasiev, M. S., Budanova, E. V., Boshjan, R. E., Likhanskaya, E. I., et al. (2020) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-tso-1450 · Cited by 3
Candidemia: An Infection Prevention Issue?
Ostrosky‐Zeichner, L. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab112 · Cited by 2
El-Atoum, M., Chen, G. L., Bonnewell, J. P., Segal, B. H., & Almyroudis, N. G. (2025) · Mycoses · doi:10.1111/myc.70136 · Cited by 1
Castelló-Abiétar, C., Alaguero, M., García-Carús, E., García-Prieto, E., Bolaños, S., Fernández-Suárez, J., & Garcia, T. P. (2026) · Journal of Fungi · doi:10.3390/jof12060428 · Cited by 1
Mascellino, M. T., & Oliva, A. (2015) · Journal of Clinical & Experimental Pathology · doi:10.4172/2161-0681.1000e120 · Cited by 1
Atmaja, R. F. D., Sulistyoningrum, D. C., Huriyati, E., Sadewa, A. H., & Susilowati, R. (2016) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci004801201602 · Cited by 1
Candidiasis and the impact of flow cytometry on antifungal drug discovery
Ku, T. S. N., Bernardo, S. M., Walraven, C. J., & Lee, S. A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1377179 · Cited by 1
Chen, Y. (2019) · Springer eBooks · doi:10.1007/978-981-13-9459-1_16 · Cited by 1
Prevalence of Candida in Blood Cultures from in patients at a Teaching Hospital in Brazil
de Macedo, V. S. O., Oliveira, S. C. D. S., Rodrigues, M. R. P., Coelho, C. G. V., & Barbosa, F. C. B. (2019) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2019.812.244
Dao, V. H., & Vu, T. K. (2021) · Journal of Chemistry · doi:10.1155/2021/7526347 · Cited by 2
Introduction to medical mycology
Warnock, D. W. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0001 · Cited by 1
Mohammad, T. H., Risan, M. H., Kadhom, M. A., & Yousif, E. (2021) · Bionatura · doi:10.21931/rb/2021.06.03.19 · Cited by 1
Boric Acid Solution Inhibits Candida albicans Infections in Mouse Skin via the IL-23/Th17 Axis
Liu, Z., Liu, Q., Xu, Y., Han, Z., Zhang, L., & Li, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.919677 · Cited by 1
Hwang, Y.-Y., Kang, O., Park, C.-E., Lee, M., Kim, Y.-K., Huh, H. J., & Lee, N. Y. (2022) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2022.54.2.133 · Cited by 1
Hwang, Y.-Y., Kang, O., Park, C.-E., Hong, S.-N., Kim, Y.-K., Huh, H. J., & Lee, N. Y. (2022) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2022.54.2.110 · Cited by 1
Antifungal and Antibiofilm Activities of Some Essential Oils Against Candida spp
Atron, B., AHAMADA, H., Kafa, A. H. T., Çelik, C., & Hasbek, M. (2022) · Cumhuriyet Science Journal · doi:10.17776/csj.1102028 · Cited by 1
An Overview of Candidemia Patients in Tertiary Hospital, Surabaya, Indonesia
Pratiwi, C. A., Airlangga, P. S., & Endraswari, P. D. (2022) · International Journal of Research Publications · doi:10.47119/ijrp10011111020224019 · Cited by 1
Naphthylthiazoles: a class of broad-spectrum antifungals
Hagras, M., Abutaleb, N. S., Ezzat, H. G., Salama, E. A., Seleem, M. N., & Mayhoub, A. S. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00323j · Cited by 1
Biodetection Strategies for Selective Identification of Candidiasis
Verma, R., Gaba, S., Chauhan, N., Chandra, R., & Jain, U. (2024) · Indian Journal of Microbiology · doi:10.1007/s12088-024-01288-5 · Cited by 1
Ali, S. H., Osmaniye, D., Sağlık, B. N., Levent, S., Özkay, Y., & Kaplancıklı, Z. A. (2024) · ACS Omega · doi:10.1021/acsomega.3c07879 · Cited by 1
Successful in-vivo treatment of mice infected with Candida glabrata using silver nanoparticles
Mohammad, T. H., Risan, M. H., El-Hiti, G. A.-R., Ahmed, D. S., & Yousif, E. A. (2020) · Bionatura · doi:10.21931/rb/2020.05.04.10 · Cited by 1
Mutations in ERG 11 Gene Among FluconazolePreprint
Sheena, M. S., & Singh, R. (2024) · Preprints.org · doi:10.20944/preprints202401.0367.v1
Tennant, S. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.298
Lalvand, M., Kord, M., Ghaffarjabbari, A., & Robati, A. K. (2017) · Comparative Clinical Pathology · doi:10.1007/s00580-017-2484-5
Chinduma, A. T. M., Azócar, P. E. B., & Pareja, C. A. M. (2017) · Boletín micológico · doi:10.22370/bolmicol.2017.32.2.994
Impact of select risk factors on treatment outcome in adults with candidemia
Hill, B. K., Drew, R. H., & Wilson, D. T. (2019) · Pharmacy Practice · doi:10.18549/pharmpract.2019.3.1561
Species Diversity of Candida from Hospital Environment in Plateau State, Nigeria
Nnadi, N. E., Nanpyal, M. A., Kaduna, N., Jonathan, B., & Karaltı, İ. (2020) · American Journal of Biomedical and Life Sciences · doi:10.11648/j.ajbls.20200801.14
Issues and Concerns in the Management of Systemic Candidiasis
Fong, I. W. (2020) · Springer eBooks · doi:10.1007/978-3-030-36966-8_11
Kothalawala, M., Jayaweera, J., Arunan, S., & Jayathilake, A. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pamic.1.2020.19
Atividade in vitro de equinocandinas em biofilmes mistos de Candida spp. e Pseudomonas aeruginosa.
dos Santos, L. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-09122021-134359
Dilwali, S., & Papaliodis, G. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-09126-6_4
Fungal infections in intensive therapy units
Barnes, R. A., & Backx, M. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0036
Epidemiology of fungal disease
Mody, R. K., Cleveland, A. A., Lockhart, S. R., & Brandt, M. E. (2017) · doi:10.1093/med/9780198755388.003.0007
Self-citationHigh-Throughput Phospholipidomics of Candida Cells: From Sample Preparation to Data Analysis
Kumar, M., Prasad, R., & Singh, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2549-1_9
Antifungal Activity of Propolis against Candida Species: Propolis and Antifungal Action
Küçükateş, E. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107172
“Antifungal Susceptibility Pattern of Oropharyngeal Candidiasis in Cancer Patients”
Singh, A. K., Bisht, D., Chaudhary, J. K., & Singh, D. N. (2022) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s06.064
A Comparative Overview of Various Fungal Menaces Amidst Corona Virus Disease
C, M. H. G. D. J. (2023) · Journal of Pharmaceutical Negative Results · doi:10.47750/pnr.2022.13.s08.532
Biçer, M. (2023) · Özgür Yayınları eBooks · doi:10.58830/ozgur.pub128.c687
Felix, G. N. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-16062023-113452
Pál, S. E. (2022) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.11334
Predictors of outcomes in patients with candidemia in an Intensive Care Unit
Özel, A. S., Altunal, L. N., Şengel, B. E., Aslan, M., & Aydın, M. (2023) · Marmara medical journal · doi:10.5472/marumj.1367454
Antypenko, L., Antypenko, O., Vasilieva, I., & Kozyrieva, V. (2024) · ГРААЛЬ НАУКИ · doi:10.36074/grail-of-science.15.03.2024.080
Викторовна, С. Л., Balalaeva, M. A., Dymova, O. V., Chernova, E. V., Лукина, М. В., Krucenko, A. A., Petrenko, D. А., Dmitrieva, S. S., & Eremenko, A. A. (2024) · Messenger of Anesthesiology and Resuscitation · doi:10.24884/2078-5658-2024-21-4-85-91
Portela, F. V. M., de Andrade, A. R. C., Pereira, L. M. G., da Silva, B. N., Peixoto, P. H. S., Amando, B. R., Fiallos, N. D. M., de Souza, P. D. F. S. M., de Lima-Neto, R. G., Guedes, G. M. D. M., et al. (2024) · Biofouling · doi:10.1080/08927014.2024.2396013
Candidiasis, Drug Resistance, and Translational Research
Jha, A., & Kumar, A. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_13
Benders, P. M. B., Schouten, J. A., Vena, A., Buil, J. B., Bronkhorst, E., & Bassetti, M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10644-9 · Cited by 1
Greenberg, R. G., Fisher, B. T., & Otto, W. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00217-x
Invasive Candidiasis in Children
Rincón-Zuno, J., Caballero, L. B. M., & Carbajal, D. N. L. (2025) · Current Fungal Infection Reports · doi:10.1007/s12281-025-00505-y
Travis, L. M., Goldenberg, B. T., & Steinlauf, S. D. (2025) · Cureus · doi:10.7759/cureus.92574
Molecular analysis of ERG11 gene in azole resistant Candida Species among immunocompromised patients
Salem, A. H., Mashaly, M. E.-S., Deeb, D. R. E., Agha, S., Eldegwi, M., & Elshaer, M. Y. S. (2026) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2026.101635
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · RWTH Publications (RWTH Aachen) · doi:10.5167/uzh-280465
Trihudiyatmanto, M. (2026) · Studies in systems, decision and control · doi:10.1007/978-3-031-99466-1_19
Charlet, R. (2022) · theses.fr (ABES) · doi:10.70675/11b08f90z8d0dz43efz96ffzf2527c076034
Fonctions et biosynthèse des β-1,6-glucanes de la paroi cellulaire chez Candida albicans
Bekirian, C. (2024) · theses.fr (ABES) · doi:10.70675/b1028289z0c26z4acaz8f96z18e5c0c94464
Epidemiology of source-related candidaemia and breakthrough candidaemia in intensive care units
Şişman, A. S., Önal, U., Çalışır, B., YILMAZ, E., Kazak, E., Heper, Y., Özkaya, G., İşçimen, R., Özakın, C., Ener, B., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13830-5
Management of invasive fungal infections in the intensive care unit
Chean, D., Friol, A., Azoulay, É., & Maillard, A. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2710718
Metadata
- Authors
- Cleveland, A. A., Harrison, L. H., Farley, M. M., Hollick, R., Stein, B., Chiller, T. M., Lockhart, S. R., & Park, B. J.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Johns Hopkins University (US)
- Emory University (US)
- Corresponding author
- Cleveland, Angela Ahlquist
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-30
- Volume
- 10
- Issue
- 3
- Pages
- e0120452
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4378850
- OpenAlex
- W2044502735
- Cited by
- 304
- References
- 26
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 21 · 2023: 28 · 2022: 31 · 2021: 27 · 2020: 32 · 2019: 36 · 2018: 31 · 2017: 31 · 2016: 28 · 2015: 11
- FWCI
- 26.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- candidemia, candidemia incidence, antifungal resistance, echinocandin resistance, fluconazole resistance, Candida glabrata, Candida albicans, multidrug resistance, central venous catheters, bloodstream infection, infection control, Atlanta, Baltimore, population-based surveillance, central line-associated bloodstream infection
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida, Child, Child, Preschool, Female, Georgia, Humans, Infant, Infant, Newborn, Male, Microbial Sensitivity Tests, Middle Aged, Population Surveillance, Baltimore, Incidence, Drug Resistance, Fungal, Young Adult, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
